[{"id":"f7c4829e-2e62-4545-848d-16a332099626","acronym":"","url":"https://clinicaltrials.gov/study/NCT01216176","created_at":"2021-01-18T04:52:55.612Z","updated_at":"2024-07-02T16:36:57.496Z","phase":"Phase 2","brief_title":"A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer","source_id_and_acronym":"NCT01216176","lead_sponsor":"Joyce Marie Slingerland","biomarkers":" HER-2 • ER","pipe":" | ","alterations":" HER-2 positive • HER-2 negative • PGR positive","tags":["HER-2 • ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HER-2 negative • PGR positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e anastrozole • saracatinib (AZD0530)"],"overall_status":"Completed","enrollment":" Enrollment 71","initiation":"Initiation: 10/21/2008","start_date":" 10/21/2008","primary_txt":" Primary completion: 02/07/2018","primary_completion_date":" 02/07/2018","study_txt":" Completion: 02/07/2018","study_completion_date":" 02/07/2018","last_update_posted":"2019-07-31"}]